Tympanostomy Products Market By Product (Tube Inserters, Tympanostomy Tubes), By Material (Silicon, Fluoroplastic, Titanium, Stainless Steel), By Application (Recurrent Otitis Media With Effusion, Chronic Otitis Media) - Growth, Share, Opportunities & Competitive Analysis, 2018 – 2026

The market for tympanostomy products is expected to grow from US$ 79.3 million in 2017 to US$ 93.4 million in 2026, with a compounded annual growth rate of 1.9% from 2018 to 2026. According to the World Health Organization's (WHO) most recent research, approximately 709 million people worldwide suffer from otitis media, with 90% being children.

Market Synopsis

The introduction of novel devices and the lack of general anesthesia during insertion and removal increase the adoption rate of tube inserters among ENT surgeons.

Tube inserters are leading the product segment for the tympanostomy products market. The introduction of novel inserters and the lack of general anesthesia in the insertion and removal of tube inserters while treating recurrent otitis media with effusion infection in pediatric patients are the major factors responsible for its increased adoption rate among ENT surgeons worldwide. Tympanostomy tubes will register impressive growth in the near future due to their availability in various designs, including bioresorbable and antimicrobial-coated tubes for treating middle ear infections.

Inherent features such as biocompatibility, beveled edges resisting occlusion, and smoothness drive the fluoroplastic material market's growth.

Fluoroplastic materials are currently the dominant material segment in the tympanostomy products market. Fluoroplastic tympanostomy material market growth is driven by inherent characteristics such as a beveled shape that resists occlusion, smoothness, and excellent biocompatibility. Silicone materials have huge demand owing to their physicochemical properties, such as compliance, elasticity, and softness, which make their manipulation easy. Its extremely lubricious nature makes insertion and removal of tympanostomy products easy and safe.

The recurrent otitis media with effusion market is being driven by emerging antibiotic resistance issues and an increasing preference for tympanostomy procedures.

Recurrent otitis media with effusion is leading the application segment for the tympanostomy products market. Parameters such as the increasing preference for tympanostomy procedures and the emerging problem of antibiotic resistance drive the market growth for recurrent otitis media with effusion. Chronic otitis media is highly prevalent in pediatric patients with an upper respiratory tract infection, often resulting in redness of the tympanic membrane. Accurate diagnosis with proper medical intervention is the best possible option to prevent mucoid or purulent effusion from the middle ear region.

The rising prevalence of otitis media infection in children and the domicile of key players drive market growth in North America.

In the present scenario, North America dominates the regional segment of the market for tympanostomy products. It holds a 35% market share, primarily due to the rising prevalence of otitis media in children. As per the research findings obtained by the United States Agency for Healthcare and Quality, approximately 1 million tube insertion procedures are conducted annually in the U.S.

The presence of key players such as Atos Medical, Medtronic Plc., and Olympus Corporation in North America further consolidates market growth. Europe represents 25% of the market share on account of the affordable reimbursement scenario for tympanostomy products and the supportive regulatory environment provided by the European Medical Agency (EMA). Asia Pacific currently accounts for 15% of the market share and will be the fastest-growing market during the forecast period owing to the rising prevalence of middle ear infections and a significant rise in medical tourism.

Periods of History and Forecast

This research report presents the analysis of each segment from 2016 to 2026, considering 2017 as the base year for the research. The compound annual growth rate (CAGR) for each of the respective segments is calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

Major medical device manufacturers producing tympanostomy products are Atos Medical, Adept Medical, EON Meditech, Koken Co., Ltd., Medtronic, Plc., OtoMedics Advanced Medical Technologies, Olympus Corporation, Precepts Medical, Summit Medical Group, Teleflex Incorporated.

Key questions are answered in this report.

  • Which medical device companies are providing tympanostomy products?
  • What is the market assessment, and what are the latest market trends determined for the tympanostomy products market?
  • What is the disease etiology associated with otitis media?
  • Which features are responsible for the positive growth of tube inserters?
  • Which materials are preferred for the manufacturing of tympanostomy devices?
  • What will be the performance of the Asia Pacific regional segment during the forecast period?

Frequently Asked Question:

The market for Tympanostomy Products Market is expected to reach USD$ 93.4 Mn in 2026.

The Tympanostomy Products Market is expected to see significant CAGR growth over the coming years, at 1.9%.

The report is forecasted from 2018 -2026.

The base year of this report is 2017.

Atos Medical, Adept Medical, EON Meditech, Koken Co., Ltd., Medtronic, Plc., OtoMedics Advanced Medical Technologies, Olympus Corporation, Precepts Medical, Summit Medical. are some of the major players in the global market.

Choose License Type
Trusted By
Published Date:  Mar 2019
Category:  Medical Devices
Report ID:   59620
Report Format:   PDF
Pages:   120
Rating:    4.4 (56)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support